2212020-52-3
- Product Name：Orforglipron
- Molecular Formula：C48H48F2N10O5
- Purity：99%
- Molecular Weight：883.0
Product Details:
CasNo： 2212020-52-3
Molecular Formula： C48H48F2N10O5
Buy High Quality Orforglipron 99% Pure 2212020-52-3 On Stock
- Molecular Formula:C48H48F2N10O5
- Molecular Weight:883.0
Orforglipron(Cas 2212020-52-3) Usage
|
Description |
Orforglipron is an experimental oral medication designed to stimulate GLP-1 receptors in the body. GLP-1 receptors play a role in regulating insulin release from the pancreas, slowing down digestion, and promoting satiety. Orforglipron is a non-peptide GLP-1 receptor agonist, offering a convenient once-daily oral dosing option for individuals with type 2 diabetes and obesity. |
| Uses |
Orforglipron is being developed as a potential treatment for both type 2 diabetes and obesity. By binding to GLP-1 receptors, orforglipron stimulates insulin release from the pancreas when needed, helping to regulate blood sugar levels. Additionally, it slows down the rate at which food moves through the digestive tract, which may contribute to weight loss. |
2212020-52-3 Relevant articles
Non-peptide, once-per-day oral orforglipron to compete with established peptide-based, injectable GLP-1 receptor agonists
MA Nauck ， M Horowitz
, Lancet
Non-peptide, once-per-day oral orforglipron to compete with established peptide-based, injectable GLP-1 receptor agonistsGASTROINTESTINAL SYMPTOMS...
Study on the clinical efficacy of Orforglipron in the treatment of adult obese patients
-
Davina Moussa * 11…Louis M. Staudt MD, PhD 13
Chinese Journal of Clinical Pharmacology, 2023
Orforglipron is a non-peptide glucagon-like peptide-1 (GLP-1) receptor agonist. This study explored the clinical efficacy and safety of Orforglipron in the treatment of adult obese patients. This study was a randomized, double-blind, Placebo parallel control,...
Relevant Products
-
PralsetinibCAS：2097132-94-8
-
TinidazoleCAS：19387-91-8
-
Diatrizoic AcidCAS：50978-11-5
